At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Modeling DNA Diversity in Cardiovascular Health/Disease
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Nov 7, 2016
In Brief
An observational study for Cardiovascular Diseases and Heart Diseases. Completed.
Detailed Summary
To identify and measure DNA sequence variation in 13 genes that play a central role in key physiological functions involved in the development of cardiovascular disease, that is, genes involved in lipid metabolism, carbohydrate metabolism, and blood pressure regulation.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases
Countries--
Collaborators--
Timeline
N/ACompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 1997
First PostedMay 2000
Study CompletionJun 2003
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartAug 1, 1997
Study CompletionJun 1, 2003
TodayJul 2, 2026
Posted 26.1 years ago